Health Care & Life Sciences » Pharmaceuticals | Alvogen Korea Co. Ltd.

Alvogen Korea Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
2,026
10,687
12,240
8,677
10,399
Depreciation, Depletion & Amortization
2,260
3,032
5,165
6,135
6,685
Other Funds
85
914
947
-
-
Funds from Operations
7,277
7,269
26,539
45,531
26,391
Changes in Working Capital
7,456
7,127
11,505
3,045
4,048
Net Operating Cash Flow
179
14,395
38,044
48,577
22,343
Capital Expenditures
6,235
4,494
9,715
15,805
5,116
Sale of Fixed Assets & Businesses
8,206
16
260
174
116
Purchase/Sale of Investments
3,591
1,690
3,661
556
72
Net Investing Cash Flow
7,139
188,952
5,795
16,553
4,319
Cash Dividends Paid - Total
-
-
-
-
-
Issuance/Reduction of Debt, Net
48
80,295
10,165
6,123
1,154
Net Financing Cash Flow
37
175,526
11,112
6,123
32,663
Net Change in Cash
6,997
27,823
21,137
25,901
14,639
Free Cash Flow
5,089
16,659
34,479
46,892
20,636
Net Assets from Acquisitions
-
186,386
-
-
-
Other Sources
3,020
221
-
145
848
Change in Capital Stock
-
96,145
-
-
33,817
Exchange Rate Effect
-
2
-
-
-
Other Uses
1,444
-
-
511
94

About Alvogen Korea Co.

View Profile
Address
13/F, IFC Two
Seoul SL 07241
Korea, Republic Of
Employees -
Website http://www.Alvogenkorea.com
Updated 09/14/2018
Alvogen Korea Co., Ltd. engages in the manufacture of pharmaceutical products. It offers products for the therapeutic areas of endocrine system, urinary system, neuropsychiatry system, anti-inflammatory, antipyretic, analgesic, gastrointestinal system, cardiovascular system, dermatology, hepatitis, antibiotics, respiratory system, hormones etc. It provides pharmaceutical products in various dosage forms, including tablets, capsules, granules, powders, ampoules, vials and intravenous (IV) solutions.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.